Health
Bedside trial of COVID-19 ICU patients sees hydrocortisone improve recovery – Mirage News
Researchers have found that intravenous hydrocortisone improves recovery and survival for critically ill COVID-19 patients. The finding comes as a result…
- Researchers have found that intravenous hydrocortisone improves recovery and survival for critically ill COVID-19 patients.
- The finding comes as a result of the REMAP-CAP trial that was set up by a group of intensive care specialists from around the world to future-proof for pandemics like COVID-19.
- COVID-19 patients from more than 200 intensive care units around the world have been part of this adaptive randomised trial.
A global study, led from Mo…
Click here to view the original article.
Continue Reading
-
General13 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News13 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
Noosa News22 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General20 hours agoCrowe toasts talkback titan for platforming ‘voiceless’